Q02127 (PYRD_HUMAN) Homo sapiens (Human)

Dihydroorotate dehydrogenase (quinone), mitochondrial UniProtKBInterProSTRINGInteractive Modelling

395 aa; Sequence (Fasta)

Available Structures

85 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with brequinar analogue
4jtu
homo-2-mer31-395
2×FMN; 2×ORO; 6×SO4; 2×DET; 2×JTU;
Assess
HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH BREQUINAR ANALOG
1d3g
monomer29-395
1×SO4; 1×ACT; 1×BRE; 1×FMN; 1×ORO; 1×DDQ;
Assess
Structure of Human dihydroorotate dehydrogenase in complex with mii-4-097
3w7r
monomer29-395
1×CL; 6×DDQ; 1×W7A; 1×FMN; 22×GOL; 1×ORO; 4×SO4; 7×ACT;
Assess
HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH NOVEL INHIBITOR
6et4
monomer29-395
1×FMN; 1×DOR; 1×SDV; 1×DDQ; 4×ACY; 3×GOL; 2×SO4; 3×CL;
Assess
HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH ANTIPROLIFERATIVE AGENT A771726
1d3h
monomer29-395
1×SO4; 1×ACT; 1×A26; 1×FMN; 1×ORO;
Assess
Crystal structure of human DHODH in complex with ferulenol
6idj
monomer29-395
3×SO4; 3×ACT; 1×FMN; 1×ORO; 1×9AU;
Assess
Structure of human dihydroorotate dehydrogenase in complex with ascofuranone (open-form)
5zfb
monomer29-395
1×FMN; 1×ORO; 1×ACT; 6×SO4; 1×9BX;
Assess
The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational…
2prl
monomer29-395
1×SO4; 2×ACT; 1×FMN; 1×ORO; 1×R2C; 1×DDQ;
Assess
Dual binding mode of a novel series of DHODH inhibitors
2bxv
monomer29-395
1×SO4; 1×ACT; 1×FMN; 1×ORO; 1×3FT;
Assess
Dual Binding Mode of a Novel Series of DHODH inhibitors
2fpt
monomer29-395
4×SO4; 1×ACT; 1×FMN; 1×ORO; 1×ILB;
Assess
The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational…
2prh
monomer29-395
1×FMN; 1×ORO; 1×238; 1×DDQ;
Assess
The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational…
2prm
monomer29-395
1×FMN; 1×ORO;
Assess
Crystal structure of human DHODH in complex with BAY 2402234
6qu7
monomer30-395
1×ORO; 1×FMN; 1×JJE; 2×SO4; 4×ACT;
Assess
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibito…
6fmd
monomer30-395
1×DUH; 2×CL; 1×FMN; 6×ACT; 1×ORO; 4×GOL; 6×PGE;
Assess
Crystal structure of human DHODH in complex with inhibitor 1289
6j3b
monomer30-395
6×SO4; 1×FMN; 1×ORO; 1×B5O; 1×LDA; 2×DMS; 6×ACT; 3×CL; 2×NA;
Assess
Structure of human dihydroorotate dehydrogenase in complex with 275-10-COOMe
5zf4
monomer30-395
1×FMN; 1×ORO; 4×SO4; 5×ACT; 1×9BL;
Assess
Structure of human dihydroorotate dehydrogenase in complex with 277-11-OAc
5zf8
monomer30-395
1×FMN; 1×ORO; 4×ACT; 3×SO4; 1×9BO;
Assess
DHODH IN COMPLEX WITH LIGAND 13
7k2u
monomer30-395
1×FMN; 1×ORO; 1×VU7; 4×ACT; 4×SO4; 2×GOL; 1×PGE;
Assess
Structure of human dihydroorotate dehydrogenase in complex with 287-12-OCOiPr
5zfa
monomer30-395
1×FMN; 1×ORO; 3×ACT; 3×SO4; 1×9BU;
Assess
Structure of human dihydroorotate dehydrogenase in complex with 280-12
5zf9
monomer30-395
1×FMN; 1×ORO; 4×ACT; 2×SO4; 1×9BR;
Assess
DHODH IN COMPLEX WITH LIGAND 11
8dhf
monomer30-395
1×FMN; 1×ORO; 1×T6L; 4×ACT; 8×GOL; 5×SO4;
Assess
Structure of human dihydroorotate dehydrogenase in complex with 277-9-OH
5zf7
monomer30-395
1×FMN; 1×ORO; 2×ACT; 3×SO4; 1×CHW;
Assess
DHODH IN COMPLEX WITH LIGAND 19
8dhg
monomer29-394
1×FMN; 1×ORO; 1×T78; 2×SO4; 2×ACT; 1×GOL;
Assess
Crystal structure of human Dihydroorotate Dehydrogenase in complex with the inhibitor 2-Hydroxy-N-(…
7z6c
monomer30-395
1×FMN; 1×ORO; 1×IEQ; 1×P6G; 1×ACT;
Assess
Crystal structure of human DHODH in complex with inhibitor 1291
6j3c
monomer30-395
4×SO4; 1×FMN; 1×ORO; 1×B5X; 1×LDA;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 9…
3kvm
monomer30-395
1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×951;
Assess
DHODH IN COMPLEX WITH LIGAND 29
8dhh
monomer29-394
1×FMN; 1×ORO; 1×TMK; 3×ACT; 1×GOL; 1×SO4;
Assess
Dihydroorotate Dehydrogenase (DHODH) crystal structure in complex with small molecule inhibitor
3u2o
monomer29-394
1×FMN; 1×ORO; 1×03U; 3×ACT; 2×SO4;
Assess
Crystal structure of human DHODH with OSU-03012
6oc0
monomer30-394
1×ORO; 1×FMN; 3×SO4; 1×M4J;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 18L compound
5hin
monomer31-395
1×FMN; 1×ORO; 5×SO4; 1×1KL; 2×ACT;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with compound 18T
5hqe
monomer31-395
1×64B; 1×FMN; 1×ORO; 3×SO4; 3×ACT;
Assess
Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo…
5mut
monomer31-395
1×FMN; 1×ORO; 1×HYT; 2×ACT; 3×CL;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with S416
6m2b
monomer31-395
1×FMN; 1×ORO; 1×EZO;
Assess
Crystal structure of human DHODH in complex with inhibitor 1243
6lp8
monomer30-394
1×FMN; 1×ORO; 2×SO4; 5×ACT; 1×LDA; 1×B6O; 3×NA;
Assess
Crystal structure of human DHODH in complex with inhibitor 1214
6lp6
monomer30-394
1×FMN; 1×ORO; 2×SO4; 5×ACT; 1×LDA; 1×B6U; 3×NA;
Assess
Crystal structure of human DHODH in complex with inhibitor 0946
6jme
monomer30-394
1×FMN; 1×ORO; 3×SO4; 3×ACT; 1×LDA; 1×BVU; 3×NA;
Assess
Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo…
5mvc
monomer31-395
1×FMN; 1×ORO; 1×Y9B; 2×ACT; 5×CL;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 18X at 1.86 A resolution
4zl1
monomer31-395
1×ORO; 1×FMN; 1×18X; 4×SO4;
Assess
Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with DH03A338
4zmg
monomer31-395
1×FMN; 1×ORO; 1×4R5; 2×SO4; 1×ACT;
Assess
Complex of human dihydroorotate dehydrogenase with the inhibitor 221290
2wv8
monomer31-395
1×FMN; 1×ORO; 1×VGN; 1×DDQ; 1×ACT; 1×SO4;
Assess
Structure of DHODH in Complex with Ligand 17
8vhl
monomer30-394
1×FMN; 1×ORO; 1×A1AA2; 3×ACT; 3×SO4; 4×GOL;
Assess
Quaternary Complex of human dihydroorotate dehydrogenase (DHODH) with flavin mononucleotide (FMN), …
6vnd
monomer30-394
1×R4P; 2×DET; 2×DDQ; 1×CL; 3×NA; 1×FMN; 1×ORO; 3×ACT; 6×GOL;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with Piperine
6lzl
monomer31-395
1×ORO; 1×FMN; 1×AYR;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 057
4js3
monomer31-395
1×FMN; 1×ORO; 1×JS3; 7×SO4; 5×ACY;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 066
4jtt
monomer31-395
1×FMN; 1×ORO; 6×SO4; 1×JTT; 3×ACT;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A312
4ls1
monomer31-395
1×FMN; 1×ORO; 1×3X2; 1×SO4; 4×ACT;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with 072
4jts
monomer31-395
1×FMN; 1×ORO; 7×SO4; 2×ACT; 1×JTS;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A356
4rk8
monomer31-395
1×FMN; 1×ORO; 1×3RV; 11×SO4;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A367
4rr4
monomer31-395
1×FMN; 1×ORO; 1×3V1; 2×SO4;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A347
4rka
monomer31-395
1×FMN; 1×ORO; 6×SO4; 1×3RY;
Assess
Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with 7GF
5h2z
monomer31-394
1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×7GF;
Assess
Human dihydroorotate dehydrogenase bound to 4-quinoline carboxylic acid inhibitor 43
6cjf
monomer32-395
1×FMN; 1×ORO; 1×F54; 1×ZWI;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with No.33 compound
4ylw
monomer32-395
1×52Y; 1×FMN; 1×ORO; 10×SO4;
Assess
Dual binding mode of a novel series of DHODH inhibitors
2fpv
monomer32-395
2×ACT; 4×SO4; 1×FMN; 1×ORO; 1×ILC;
Assess
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 2
3fj6
monomer32-395
1×ORO; 1×FMN; 1×SO4; 2×ACT; 1×CIH;
Assess
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 3
3fjl
monomer32-395
1×FMN; 1×ORO; 1×SO4; 2×ACY; 1×CJH;
Assess
Crystal Structure of Human Dihydroorotate Dehydrogenase (DHODH) with Amino-Benzoic Acid Inhibitor 1…
3kvj
monomer32-395
1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×1X5;
Assess
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4
3g0u
monomer32-395
1×ORO; 1×FMN; 1×MDY;
Assess
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 1
3f1q
monomer32-395
1×FMN; 1×ORO; 1×BCE; 2×ACY; 1×SO4;
Assess
Human dihydroorotate dehydrogenase bound to a novel inhibitor
2b0m
monomer32-395
1×201; 1×FMN; 1×ORO;
Assess
Dual binding mode of a novel series of DHODH inhibitors
2fpy
monomer32-395
1×ACT; 5×SO4; 1×FMN; 1×ORO; 1×ILF;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A016
4jgd
monomer32-395
1×FMN; 1×ORO; 1×DET; 9×SO4; 1×4JG;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 6…
3kvk
monomer32-395
1×SO4; 1×FMN; 1×DOR; 1×DET; 1×6X1;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH01B0033
4ls0
monomer32-395
1×FMN; 1×ORO; 10×SO4; 1×B3B;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A313
4ls2
monomer32-395
1×FMN; 1×ORO; 5×SO4; 1×ACT; 1×3XS;
Assess
High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carb…
4igh
monomer33-395
1×FMN; 1×ORO; 1×1EA; 1×ZWI; 2×GOL;
Assess
Crystal structure of human DHODH with 18F
5h73
monomer32-394
1×7L7; 1×FMN; 1×ORO; 2×SO4; 4×ACT;
Assess
Crystal structure of human DHODH in complex with inhibitor 1223
6jmd
monomer32-394
1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×LDA; 1×BVO;
Assess
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5
3g0x
monomer33-395
1×FMN; 1×ORO; 1×MD7; 1×SO4;
Assess
Crystal structure of human DHODH in complex with inhibitor 0944
6lp7
monomer32-394
1×FMN; 1×ORO; 2×SO4; 2×ACT; 1×B6R; 1×LDA;
Assess
HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH CLASS III HISTONE DEACETYLASE INHIBITOR
6gk0
monomer32-394
1×FMN; 1×DOR; 4×ACY; 1×GOL; 5×SO4; 1×CL; 1×DDQ; 1×F1W;
Assess
Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on hydroxylated azo…
5mvd
monomer33-395
1×FMN; 1×ORO; 1×U91; 2×ACT; 3×CL;
Assess
dual binding modes of a novel series of DHODH inhibitors
2fqi
monomer33-395
2×SO4; 3×ACT; 1×FMN; 1×ORO; 1×ILH;
Assess
Structure of DHODH in Complex with Fragment 2
8vhm
monomer32-394
1×FMN; 1×ORO; 1×A1AA1; 2×SO4; 4×ACT; 2×CL;
Assess
Crystal structure of human DHODH with TAK-632
6oc1
monomer31-393
1×ORO; 1×FMN; 1×PO4; 1×1SU;
Assess
High resolution crystal structure of human dihydroorotate dehydrogenase bound with DSM338 (N-[3,5-d…
4oqv
monomer33-394
1×FMN; 1×ORO; 1×2V6; 2×ACY; 1×GOL; 2×NA; 1×SO4;
Assess
Crystal structure of human dihydroorotate dehydrogenase with ML390
5k9c
monomer34-395
1×FNR; 1×ORO; 1×MLJ; 2×SO4; 3×ACT; 2×CL; 1×GOL;
Assess
Human dihydroorotate dehydrogenase bound to napthyridine inhibitor 46
6cjg
monomer33-394
1×FMN; 1×ORO; 1×F51; 1×GOL; 1×SO4; 1×ZWI;
Assess
Crystal structure of human dihydroorotate dehydrogenase at 1.7 A resolution
5k9d
monomer37-395
1×FNR; 1×ORO; 1×CE9; 2×SO4; 3×ACT; 3×CL; 1×GOL;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with amino-benzoic acid inhibitor 7…
3kvl
monomer36-394
1×SO4; 1×FMN; 1×DOR; 1×DET; 1×ACT; 1×7Z5;
Assess
Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor
3zwt
monomer40-395
1×FMN; 1×ORO; 2×SO4; 1×KFZ; 2×ACT; 1×CL;
Assess
Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor
3zws
monomer40-395
1×FMN; 1×ORO; 2×SO4; 1×CL; 1×AVQ; 2×ACT;
Assess
Crystal structure of human dihydroorotate dehydrogenase (DHODH) with DH03A048
4rli
monomer45-394
1×FMN; 1×ORO; 1×3SH;
Assess
Human DHODH bound to inhibitor IPP/CNRS-A017
6syp
monomer49-395
1×FMN; 1×ORO; 1×SO4; 1×M0B;
Assess
N-terminal microdomain of 34-mers from HsDHODH - N-t(DH)
5tce
monomer32-65
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3u2o.1.Amonomer0.9229-394
1×FMN; 1×ORO; 1×03U;100.00
Assess